Committed to the Highest Standards of Integrity
Foresight, established in 2016, has grown into a trusted name in venture capital and private equity, with a strong presence in both Japan and international markets. We serve a wide range of clients – including institutional investors, high-net-worth individuals, and families – delivering access to diverse asset classes and strategic investment opportunities.
Our philosophy is built on a clear understanding of market trends, industry shifts, and long-term growth potential. Backed by deep expertise and global networks, our team of seasoned professionals identifies high-potential ventures and companies. Through strategic guidance, operational support, and financial resources, we empower our portfolio partners to scale effectively and achieve sustainable success.
Fiduciary
We act with integrity and put your interests first, safeguarding your long-term financial success.
Integrated
Comprehensive wealth management and investment solutions, seamlessly connecting global opportunities.
Personalized
Tailored strategies shaped around your goals, with proactive insights and hands-on guidance.
Experienced
A seasoned team leveraging global expertise and networks to deliver sustainable results.
Annual Performance
Top Performer: Jinko Solar Co., Ltd. (688223.SS) delivered an outstanding 198% return, turning a pre-IPO investment into a multi-million-dollar exit.
The year 2022 was a period of significant capital appreciation for Foresight’s clients, particularly those invested in our pre-IPO opportunities. Our strategic focus on high-growth sectors, especially in technology and biotech, yielded a Net Portfolio Return of 111.40% for the selected IPO portfolio.
A total of $27,900,000.00 was deployed across 8 pre-IPO investments that successfully exited via Initial Public Offering (IPO) in 2022. The portfolio generated a remarkable Net Profit of $31,080,600.00.
Top Performer: Jin Medical International (ZJYL) delivered an outstanding 400% return, turning a pre-IPO investment into a multi-million dollar exit. Strategic Exit: Our investment thesis for Belite Bio (BLTE) was validated by its strong market debut.
Our strategic focus on high-growth sectors, especially in technology and biotech, yielded a Net Portfolio Return of 142.15% for the selected IPO portfolio.
A total of $31,250,000.00 was deployed across 9 pre-IPO investments that successfully exited via Initial Public Offering (IPO) in 2023. The portfolio generated a remarkable Net Profit of $44,421,875.00.
Top Performer: Reddit (RDDT) delivered an outstanding 600% return, turning a pre-IPO investment into a multi-million-dollar exit. Strategic Exit: Our investment thesis for RayzeBio (RYZB) was validated by its strong market debut.
Our strategic focus on high-growth sectors, especially in technology and biotech, yielded a Net Portfolio Return of 488.12% for the selected IPO portfolio.
A total of $25,200,000.00 was deployed across 6 pre-IPO investments that successfully exited via Initial Public Offering (IPO) in 2024. The portfolio generated a remarkable Net Profit of $123,006,240.00.
Navigating Local and Global Markets
Foresight combines local expertise with global reach to unlock opportunities in both Japanese and international markets. Based in Japan, we leverage strong networks and insights to access diverse investments while identifying cross-border opportunities that meet evolving client needs.
Our portfolio spans technology, healthcare, consumer goods, finance, and real estate, ensuring diversification and long-term growth. With a proven track record of partnering with high-growth ventures and delivering successful outcomes, Foresight Japan is a trusted partner in venture capital and private equity for institutional and individual investors alike.
“Our purpose is to help people and organizations dream bigger, move faster, and build better tomorrows for all. Talk to one of our Professional Relationship Managers and we can impress you with our approach.”
Download Our Corporate Profile
- 2025
